In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a ...
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers ...
As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...
A new line of frozen foods will cater to users of weight loss drugs like Ozempic and Wegovy.Nestlé's Vital Pursuit brand will ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...
President Biden says he wants to reduce drug prices, and the promise of semaglutide and tirzepatide presents an opportunity ...
As the global focus on health and weight management intensifies, Nestle has announced the launch of Vital Pursuit, a brand ...
Large corporations have started adding health insurance coverage for blockbuster weight-loss and diabetes drugs including ...
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on ...
Known for brands like Stouffer's, Häagen-Dazs and DiGiorno, the global company is now introducing a new food line, Vital ...